Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Nasopharyngeal Carcinoma × nedaplatin × Clear all

Phase

Status

Unknown 5 Completed 3 Terminated 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 10 Capecitabine 7 Gemcitabine 6 toripalimab 5 Fluorouracil 5 tislelizumab 4 sintilimab 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Taxes 2 Drug Therapy 2 spartalizumab 1 pembrolizumab 1 palbociclib 1 nedaplatin 1 lobaplatin 1 Valganciclovir 1 Therapeutics 1 Sodium Fluoride 1 Single Person 1 Radiation 1 Leyk 1 LY-2157299 1 Induction Chemotherapy 1 Docosahexaenoic Acids 1 Docetaxel 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03503136 2018-05-11

NX-NPC

Sun Yat-sen University

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡